YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

In vitro and In vivo Activities Studies of Chois Mastic Using Self-microemulsifying Drug Delivery System (SMEDDS) against Helicobactor pylori

자가미세유화시스템을 이용한 매스틱의 헬리코박터파일로리 대한 In vitro 및 In vivo 활성 연구

  • Received : 2010.08.17
  • Accepted : 2010.10.31
  • Published : 2011.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Mastic is a bleed resin formed in pistacia lentiscus tree extract form the anacatdiaceae family. Mastic is used as a food ingredient in the Mediteraanean resin, and has been used by local inhabitants as a traditional medicine for relief of upper abdominal discomfort, dyspepsiaand peptic ulcer. Clinically, mastic has been effective in the treatment of benign gastric and duodenal, ulcers, giving symptomatic relief and endoscopically proven healing. In this study, to enhance activiteies of poorly water soluble Mastic with oils, surfactants and cosurfactants and then the mixure was microemulsified in aqueous media under condition of gentle agitation and digestive motility that would be encountered in the gastrointestinal tract. Formulation development and screening were based on phase diagrams and characteristics of resultant microemulsion. For optimum mastic formulation, microemulsions with various ratio (w/w%) of mastics, oils, surfactants and cosurfactants were prepared and their solubility was evaluated by monitoring particles size in their buffer through visual asessment and electrophoretic light scattering spectrophotomerter (ELS). In vitro activity of self microemulsified mastic (SME mastic) was determined by minimum ingibition concentration (MIC) test against a panel of Helicobacter pylori (H. pylori) clinical strains. Additionally, in vivo activity of SME masitc was investigated us mouse infected by CH275 of H. pylori. The mean diameter of SME mastic was less then 100 nm in water and SME mastic was showed similar antiboisis effect compared to tometronidazole, clarithromycin and omeproazole. Consequently, SME mastic would be effective system to exterminate H. pylori. If mastic were dose with combined treatment, mastic might augur well for effect of H. pylori eradication as good remedy.

Keywords

References

  1. Van Der Hulsta, R. W. M. and Tytgata, G. N. J. : Helicobacter pylori and peptic ulcer disease. Scandinavian Journal of Gastroenterology, 31, S220, 10 (1996). https://doi.org/10.3109/00365529609094744
  2. Tadataka Yamada, John G. Dennis Ahnen and David H. Aipers : National institute of health consensus conference. Helicobacter pylori in peptic ulcer disease. JAMA, 272, 65 (1994). https://doi.org/10.1001/jama.1994.03520010077036
  3. De Boer, W. A. and Tytgat, G. N. : The best therapy for Helicobacter pylori infection: should efficacy or side effect profile determine our choice. Scand J. Gastroenterol, 30, 401 (1995). https://doi.org/10.3109/00365529509093298
  4. Van der Hulst, R. W., Keller, J. J., Rauws, E. A. and Tytga, G. N. : Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter, 1, 6 (1996). https://doi.org/10.1111/j.1523-5378.1996.tb00003.x
  5. Noach, L. A., Langenberg, W. L., Bertola, M. A., Dankert, J. and Tytgat, G. N. : Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J. Infec. Dis., 26, 321 (1994). https://doi.org/10.3109/00365549409011802
  6. Mills, J. S. and White, R. : Natural resins of art and archaeology their sources, chemistry and identification. Studies in Conservation, 22, 12 (1977). https://doi.org/10.2307/1505670
  7. Mills, J. S. and White, R. : The identity of the resins from the late bronze age shipwreck at ULU BURUN. Archaeometry, 31, 31 (1989).
  8. Papageorgiou, V. P., Bakola-Christianopoulou, M. N., Apazidou, K. K. and Psarros, E. E. : Gas chromatographic-mass spectroscopic analysis of the acidic triterpenic fraction of mastic gum. Journal of Chromatography A. 769, 263 (1997). https://doi.org/10.1016/S0021-9673(96)01032-1
  9. Klass Jan van den Berg, Jerre van der Horsta and Jaap J. Boona : Cis-1,4-poly-${\beta}$-myrcene; the structure of the polymeric fraction of mastic resin (Pistacia lentiscus L.) elucidated. Tetrahedron Letters, 39, 2645 (1998). https://doi.org/10.1016/S0040-4039(98)00228-7
  10. Al Habbal, M. J., Al Habbal, Z. and Huwez, F. U. : A doubleblind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin. Exp. Pharmacol. Physiol., 11, 541 (1984). https://doi.org/10.1111/j.1440-1681.1984.tb00864.x
  11. Michael F. Loughlin, Dlawer A. Ala'Aldeen and Peter J. Jenks : Monotherapy with mastic does not eradicate Helicobacter pylori infection from mice. Journal of Antimicrobial Chemotherapy, 51, 367 (2003). https://doi.org/10.1093/jac/dkg057
  12. James R. Bebb, Nathalie Bailey-Flitter, Dlawer Ala'Aldeen and John C. Atherton : Mastic gum has no effect on Helicobacter pylori load in vivo. Journal of Antimicrobial Chemotherapy, 52 522 (2003). https://doi.org/10.1093/jac/dkg366
  13. Warren, J. R. and Marshall, B. : Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1, 8336, 1273 (1983).
  14. van den Berg, K. J., van der Horsta, J., Boona, J. J. and Sudeiijerb, O. O. : Cis-1,4-poly-${\beta}$-myrcene; the structure of the polymeric fraction of mastic resin (Pistacia lentiscus L.) elucidated, Tetrahedron Letters, 39, 2645 (1998). https://doi.org/10.1016/S0040-4039(98)00228-7
  15. Prince, L. M. : A theory of aqueous emulsion I. Negative interfacial tension at the oil/water interface. Colloid Interface Sci., 23, 165 (1967). https://doi.org/10.1016/0021-9797(67)90099-9
  16. Shinoda, K. and Friberg, S. : Microemulsions: Colloidal aspects. Colloid Interface Sci., 4, 281 (1975). https://doi.org/10.1016/0001-8686(75)85006-8
  17. Kim, H. S., Lee, S. K., Choi, S. U., Park, H. S., Jeon, H. J. and Choi, Y. W. : Improved dissolution characteristics of ibupofen employing self-microemulsigying drug delibery system and their boiavailability in rats. J. Kor. Pharm. Sci., 32, 27 (2002).
  18. Tabony, J. : Formation of cubic structures in microemulsions containing equal volumes of water and oil. Nature, 319, 400 (1986). https://doi.org/10.1038/319400a0
  19. Kim, K. H. and Park, E. S. : Improvement of dissolution rate of poorly water soluble drug using self-microemulsifying drug delivery system. J. Kor. Pharm. Sci., 29, 37 (1999).
  20. Bok, H. S., Kim, M. M. and Choi, K. E. : Comparative study using MIC test for cefazedone and other first generation cephalosporins. Korean Journal of Clinical Pharmacy, 5, 13 (1995).
  21. Lee, B. J., Shin, Y. H., Seo, S. H. and Sa, H. G. : 제제학, 한림원, Seoul (2004).
  22. Attwood, D., Mallon, C. and Taylor, C. J. : A study on factors influencing the droplet size in nonionic oil-in-water microemulsions. Int. J. Pharm., 88, 417 (1992). https://doi.org/10.1016/0378-5173(92)90341-X
  23. Charman, S. A., Charman, W. N., Rogge, M. C., Wilson, T. D., Dutko, F. J. and Pouton, C. W. : Self-emulsigying drug delivery system: Formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm. Res., 9, 87 (1992). https://doi.org/10.1023/A:1018987928936
  24. Ahn, Y. S., Song, J. H., Kang, B. K. and Kim, M. S. : Preparation and characterization of liquefied ibuprofen using self-microemulsion drug delivery system (SMEDDS). Pharm. Sci., 34, 35 (2004). https://doi.org/10.4333/KPS.2004.34.1.035
  25. Goddeeris, C., Goderis, B. and Mooter, G. B. D. : Lyotropic, liquid crystalline nanostructures of aqueous dilutions of SMEDDS revealed by small-angle X-ray scattering: Impact on solubility and drug release. European Journal of Pharmaceutical Sciences, 40, 110 (2010). https://doi.org/10.1016/j.ejps.2010.03.005
  26. Chiba, N., Rao, B. V. and Raemaker, J. W. : Meta-analysis of the efficacy of antibiotic therapy in eradication Helicobacter pylori. Am. J. Gastroentero., 87, 1716 (1992).
  27. Grayson, M. L., Eliopoulos, G. M., Ferraro, M. J. and Moellering, R. C. : Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. European Journal of Clinical Microbiology & Infectious Diseases 8, 888 (1989). https://doi.org/10.1007/BF01963775
  28. T. Ulf Westblom and Dennis E. Duriex : Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Digestive Diseases and Sciences, 36, 25 (1991). https://doi.org/10.1007/BF01300082
  29. Nwokolo, C. U., Lewin, J. F., Hudson, M. and Pounder, R. E. : Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology, 102, 163 (1992). https://doi.org/10.1016/0016-5085(92)91796-7
  30. Nagata, K., Satoh, H. and Iwahi, T. : potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: Unique action selective for H. pyloni cells. Antimicrob Agents Chemother, 37, 769 (1993). https://doi.org/10.1128/AAC.37.4.769
  31. Nakshabendi, I. M., Zhang, Q. B. and Mokhashi, M. : Effect of Omeprazole Therapy on the Survival of Helicobacter pylori, urease activity, and antral gastric histology in patients with duodenal ulcer. Helicobacter, 1, 155 (1996). https://doi.org/10.1111/j.1523-5378.1996.tb00030.x